Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Artivion Inc’s stock clocked out at $44.83, up 3.92% from its previous closing price of $43.14. In other words, the price has increased by $3.92 from its previous closing price. On the day, 0.66 million shares were traded. AORT stock price reached its highest trading level at $45.07 during the session, while it also had its lowest trading level at $43.12.
Ratios:
To gain a deeper understanding of AORT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 276.12. For the most recent quarter (mrq), Quick Ratio is recorded 2.69 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.61.
On June 17, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $35.
On October 23, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $33.JMP Securities initiated its Mkt Outperform rating on October 23, 2024, with a $33 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’25 when Mackin James P sold 12,500 shares for $42.32 per share. The transaction valued at 528,988 led to the insider holds 852,783 shares of the business.
Mackin James P bought 12,500 shares of AORT for $528,991 on Aug 15 ’25. On Aug 12 ’25, another insider, Holloway Jean F, who serves as the SVP, General Counsel of the company, sold 23,356 shares for $43.01 each. As a result, the insider received 1,004,610 and left with 172,129 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AORT now has a Market Capitalization of 2115245312 and an Enterprise Value of 2325508352. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.22 while its Price-to-Book (P/B) ratio in mrq is 5.03. Its current Enterprise Value per Revenue stands at 5.741 whereas that against EBITDA is 51.084.
Stock Price History:
The Beta on a monthly basis for AORT is 1.65, which has changed by 0.6897851 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, AORT has reached a high of $43.97, while it has fallen to a 52-week low of $21.97. The 50-Day Moving Average of the stock is 33.49%, while the 200-Day Moving Average is calculated to be 54.45%.
Shares Statistics:
It appears that AORT traded 410.84K shares on average per day over the past three months and 726340 shares per day over the past ten days. A total of 47.10M shares are outstanding, with a floating share count of 44.01M. Insiders hold about 6.75% of the company’s shares, while institutions hold 88.08% stake in the company. Shares short for AORT as of 1753920000 were 1208000 with a Short Ratio of 2.94, compared to 1751241600 on 1425190. Therefore, it implies a Short% of Shares Outstanding of 1208000 and a Short% of Float of 3.15.
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is $0.2, with high estimates of $0.24 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.72 and $0.54 for the fiscal current year, implying an average EPS of $0.65. EPS for the following year is $0.85, with 4.0 analysts recommending between $0.98 and $0.64.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $110.44M. It ranges from a high estimate of $112M to a low estimate of $109.5M. As of the current estimate, Artivion Inc’s year-ago sales were $95.78MFor the next quarter, 7 analysts are estimating revenue of $115.59M. There is a high estimate of $117M for the next quarter, whereas the lowest estimate is $113.5M.
A total of 7 analysts have provided revenue estimates for AORT’s current fiscal year. The highest revenue estimate was $439.02M, while the lowest revenue estimate was $435M, resulting in an average revenue estimate of $438M. In the same quarter a year ago, actual revenue was $388.54MBased on 7 analysts’ estimates, the company’s revenue will be $485.29M in the next fiscal year. The high estimate is $491.3M and the low estimate is $473M.
